Report overview
The global Core Needle Biopsy for Soft Tissue market was valued at million in 2024 and is projected to reach US$ million by 2032, at a CAGR of %during the forecast period.
A core needle biopsy is a procedure where a doctor takes a sample from a suspicious lump or area of tissue. The report mainly studies core biopsy needles.
The U.S. market size is estimated at $ million in 2024, while China is to reach $ million.
Below 10 cm segment will reach $ million by 2032, with a % CAGR in next six years.
The global key manufacturers of Core Needle Biopsy for Soft Tissue include BD, Medtronic, IZI Medical, Medax, ARGON MEDICAL, Ranfac, Merit Medical, INRAD, etc. In 2024, the global top five players had a share approximately % in terms of revenue.
We have surveyed the Core Needle Biopsy for Soft Tissue manufacturers, suppliers, distributors, and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Core Needle Biopsy for Soft Tissue, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Core Needle Biopsy for Soft Tissue. This report contains market size and forecasts of Core Needle Biopsy for Soft Tissue in global, including the following market information:
Global Core Needle Biopsy for Soft Tissue market revenue, 2020-2025, 2026-2032, ($ millions)
Global Core Needle Biopsy for Soft Tissue market sales, 2020-2025, 2026-2032, (K Units)
Global top five Core Needle Biopsy for Soft Tissue companies in 2024 (%)
Total Market by Segment:
Global Core Needle Biopsy for Soft Tissue market, by Type, 2020-2025, 2026-2032 ($ millions) & (K Units)
Global Core Needle Biopsy for Soft Tissue market segment percentages, by Type, 2024 (%)
Below 10 cm
10-15 cm
15-20 cm
Above 20 cm
Global Core Needle Biopsy for Soft Tissue market, by Application, 2020-2025, 2026-2032 ($ Millions) & (K Units)
Global Core Needle Biopsy for Soft Tissue market segment percentages, by Application, 2024 (%)
Hospitals & Clinics
Ambulatory Surgical Centers
Others
Global Core Needle Biopsy for Soft Tissue market, by region and country, 2020-2025, 2026-2032 ($ millions) & (K Units)
Global Core Needle Biopsy for Soft Tissue market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Core Needle Biopsy for Soft Tissue revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Core Needle Biopsy for Soft Tissue revenues share in global market, 2024 (%)
Key companies Core Needle Biopsy for Soft Tissue sales in global market, 2020-2025 (estimated), (K Units)
Key companies Core Needle Biopsy for Soft Tissue sales share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
BD
Medtronic
IZI Medical
Medax
ARGON MEDICAL
Ranfac
Merit Medical
INRAD
Outline of Major Chapters:
Chapter 1: Introduces the definition of Core Needle Biopsy for Soft Tissue, market overview.
Chapter 2: Global Core Needle Biopsy for Soft Tissue market size in revenue and volume.
Chapter 3: Detailed analysis of Core Needle Biopsy for Soft Tissue manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Core Needle Biopsy for Soft Tissue in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Core Needle Biopsy for Soft Tissue capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
